Introduction to the Duplomb Law Controversy
On August 4, 2025, the French National Council of the Order of Doctors (CNOM) publicly opposed the Duplomb Law, which seeks to reintroduce the pesticide acetamiprid in France. This move aligns CNOM with millions of citizens and various civil society actors who have voiced their concerns. The law, passed on July 9, has sparked significant debate due to the pesticide’s potential environmental and health impacts.
Background on Acetamiprid and Its Controversies
Acetamiprid, part of the neonicotinoid family, was banned in France in 2018 due to its harmful effects on bee populations and potential risks to human health. Despite a comprehensive study by the French Agency for Food, Environmental and Occupational Health & Safety (Anses) between 2026 and 2027, which found no direct harmful effects on human health under regulated conditions, the CNOM remains cautious. The medical community is particularly concerned about the pesticide’s possible links to neurodevelopmental disorders, pediatric cancers, and chronic diseases.
CNOM’s Position and Rationale
Jean-Marcel Mourgues, CNOM’s vice-president, emphasized the importance of precaution, citing substantial scientific evidence that raises serious doubts about the safety of acetamiprid. The CNOM’s stance is rooted in its commitment to public health and the ethical obligations outlined in the medical code of ethics, which prioritize human life and dignity.
Environmental Health as a Priority
Under its current leadership, CNOM has prioritized environmental health, recognizing the gap between scientific knowledge and regulatory decisions. The council advocates for the application of the precautionary principle, urging for preventive measures against toxic exposures that could lead to significant health issues.
Addressing Agricultural Concerns
While acknowledging the challenges faced by the agricultural sector, CNOM insists on finding alternative solutions that do not compromise public health. Dr. Mourgues, with his agricultural background, stresses the need for solutions that do not expose the population to potentially harmful substances.
Call for Action and Future Steps
CNOM calls for immediate action to integrate environmental health into public health policy. This initiative will involve collaboration with medical professionals, scientific experts, farmers, policymakers, and health service users to develop a comprehensive approach to health and environmental issues.
Neonicotinoids in Europe: Regulatory Landscape
The use of neonicotinoids in agriculture has been restricted across Europe due to their impact on pollinators. The European Union has progressively limited these substances, with only two currently authorized for phytopharmaceutical use. In France, the use of neonicotinoids has been banned since 2018, except for acetamiprid, which remains authorized at the European level.
Conclusion
The CNOM’s opposition to the Duplomb Law underscores the ongoing debate over pesticide use and public health. By advocating for the precautionary principle and prioritizing environmental health, CNOM aims to protect public health and ensure that regulatory decisions align with scientific evidence.
🔗 **Fuente:** https://francais.medscape.com/voirarticle/3613186